Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI
Clinical Genitourinary Cancer · 2023
DOI: 10.1016/j.clgc.2023.06.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genitourinary Cancer, 2023. Verfasst von Pietro Pepe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Urology Unit, Imaging Department, Cannizzaro Hospital, Catania, Italy. Electronic address: piepepe@hotmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION/BACKGROUND: To evaluate the accuracy of 68Ga-PSMA PET/CT versus mpMRI targeted biopsy (TPBx) in the diagnosis of clinically significant prostate cancer (csPCa) in men high risk for PCa. MATERIALS AND METHODS: From January 2021 to March 2023, 125 men with clinical parameters high risk for PCa were evaluated by mpMRI and 68Ga-PSMA PET/CT; median PSA was 32.5 ng/mL (range: 12-160 ng/mL) and 60/125 (48%) had abnormal digital rectal examination. The mpMRI lesions with PI-RADS scores ≥ 3 and/or 68Ga-PSMA areas characterized by a standardized uptake value (SUVmax) values ≥ 8 were submitted to TPBx (4 cores); in addition, all the patients underwent systematic transperineal prostate biopsy (18 cores) under sedation and antibiotic prophylaxis. RESULTS: In 80 of 125 men (64%) a csPCa was found: 10 (12.5%) had a ISUP Grade Group 3 (GG), 45 (56.2%) a ISUP GG4 and 25 (31.2%) ISUP GG5. The median intraprostatic 68Ga-PSMA SUVmax was 42.3 (range:10.5-164) and 72 of 80 (90%) had a PI-RADS score ≥ 3. 68GaPSMA PET/CT showed the presence of metastases in 20 of 80 (25%) men: the median SUVmax in bone (15 cases) and nodes (40 cases) metastases was 55 and 47, respectively. Accuracy of 68Ga PSMA PET/CT (SUVmax cut-off ≥ 8) versus mpMRI PI-RADS score ≥ 3 in the diagnosis of csPCa was 92 versus 86.2%. CONCLUSION: 68GaPSMA PET/CT demonstrated a good diagnostic accuracy as a single procedure for the diagnosis and staging of high-risk PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Unit, Imaging Department, Cannizzaro Hospital, Catania, Italy. Electronic address: piepepe@hotmail.com.
- Urology Unit, Imaging Department, Cannizzaro Hospital, Catania, Italy.
Zitieren
APA
Pepe, P., & Pennisi, M. (2023). Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2023.06.007
Vancouver
Pepe P, Pennisi M. Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI. Clinical Genitourinary Cancer. 2023. doi:10.1016/j.clgc.2023.06.007
BibTeX
@article{Pepe2023,
author = {Pepe, Pietro and Pennisi, Michele},
title = {Targeted Biopsy in Men High Risk for Prostate Cancer: 68Ga-PSMA PET/CT Versus mpMRI},
journal = {Clinical Genitourinary Cancer},
year = {2023},
doi = {10.1016/j.clgc.2023.06.007}
}
EUVIMED